• Christie Brinkley is the new face for Xeomin®/Bocouture® and Ultherapy®

    During her 45-year span in the beauty and fashion industries, Christie Brinkley has maintained her youthful appearance. Through the partnership with Merz, why she chose to have to have treatments with Xeomin®/Bocouture® (incobotulinumtoxinA) and Ultherapy® to remain looking timeless and natural at age 63.

    Learn more about the non-surgical lift that's making beautiful changes arround the world.

    Read more
  • Dedicated to the development of botulinum neurotoxin for therapeutic use

    For patients with movement disorders, botulinum neurotoxin is often the treatment of choice. Merz´s expertise in this area has produced the only botulinum neurotoxin free from complexing proteins.

    Read more

    We are constantly working to advance new treatment standards and improve the quality of research, education and patient care.

    Read more
  • Merz celebrates its 110th anniversary

    110 years ago, on March 9, 1918, the pharmacist and chemist Friedrich Merz founded the Chemische Fabrik Merz & Co. in Frankfurt am Main, Germany. Today, the company is still family-owned, but it has evolved from a mid-sized pharmaceutical company into a leading global provider in the fields of aesthetics and neurotoxins.

    Read more

    The motto of Friedrich Merz, who was born in 1884 in the town of Groß-Bieberau in the German Odenwald mountain range, was: “Trust yourself, be different, and invent products that are truly needed.“ 110 years later we are still indebted to this motto at Merz.

    Read more
  • Foster growth and create value

    Merz offers funding in early stage projects from emerging companies or academic institutions. In addition to our financial investment, we also offer provision of expertise.

    Read more

    As a leading international Aesthetics company we plan to invest globally in aesthetic healthcare companies pursuing innovative, breakthrough science.

    Read more

We envision new ways to improve the lives of our patients all over the world.


Merz Turns 110 and Continues its Success Story

Frankfurt am Main, Germany /

110 years ago, on March 9, 1908, Friedrich Merz founded the Chemische Fabrik Merz & Co. in Frankfurt am Main, Germany. Today, the traditional company in Frankfurt is still family-owned,…

Read more

Merz Names Terri L. Phillips, M.D., Vice President and Head of Global Medical Affairs

Frankfurt am Main, Germany /

Merz today announced that Terri L. Phillips, M.D., F.A.A.P., has been named Vice President and Head of Global Medical Affairs, effective January 2, 2018. Dr. Phillips will oversee the global…

Read more

Professor Aaron Gitler Receives the Friedrich Merz Guest Professorship 2017

Frankfurt am Main /

The geneticist Aaron Gitler has been appointed to the 2017 Friedrich Merz Guest Professorship. The professor for genetics at Stanford University, California, researches the causes of neurodegenerative diseases such as…

Read more


If you would like to submit a speculative application or apply for an open position, please make sure
to use only our job portal, which you can find at the following link:

Please note that we cannot consider your application if you send it via any other channel.

* mandatory fields

Please note that if you submit information to Merz all materials submitted by electronic or physical communication will be deemed non-confidential. Do not submit any information or other materials that you consider to be confidential or proprietary. While we have no intention to publicly disclose any details of your proposal, we may refer to select experts within or outside the Merz network for evaluation.